APA (7th ed.) Citation

WH, C., YC, W., HT, L., CM, W., LY, L., YJ, W., . . . FS, Y. (2026). FNDC5/Irisin Attenuates TGF-β-induced Fibroblast Differentiation Via AMPK/Nrf2 Signaling and Mitochondrial Stabilization in Subepithelial Fibrosis. Inflammation, 49(1), . https://doi.org/10.1007/s10753-025-02438-7

Chicago Style (17th ed.) Citation

WH, Cheng, Wu YC, Li HT, Weng CM, Lin LY, Wu YJ, Chen BC, Lin CH, and Yuliani FS. "FNDC5/Irisin Attenuates TGF-β-induced Fibroblast Differentiation Via AMPK/Nrf2 Signaling and Mitochondrial Stabilization in Subepithelial Fibrosis." Inflammation 49, no. 1 (2026). https://doi.org/10.1007/s10753-025-02438-7.

MLA (9th ed.) Citation

WH, Cheng, et al. "FNDC5/Irisin Attenuates TGF-β-induced Fibroblast Differentiation Via AMPK/Nrf2 Signaling and Mitochondrial Stabilization in Subepithelial Fibrosis." Inflammation, vol. 49, no. 1, 2026, https://doi.org/10.1007/s10753-025-02438-7.